Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Deschatelets Pascal Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 4 Deschatelets Pascal (Chief Scientific Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Sold 12,000 shares @ $40.38, valued at $484.6k
Exercised 18,500 options to buy @ $2.67, valued at $49.4k
10/10/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
10/10/2023 144 Form 144 - Report of proposed sale of securities:
08/09/2023 4 Deschatelets Pascal (Chief Scientific Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Sold 12,000 shares @ $23.66, valued at $283.9k
Exercised 18,500 options to buy @ $2.67, valued at $49.4k
08/08/2023 144 Form 144 - Report of proposed sale of securities:
07/11/2023 4 Deschatelets Pascal (Chief Scientific Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Sold 12,000 shares @ $84.55, valued at $1M
Exercised 18,500 options to buy @ $2.67, valued at $49.4k
07/10/2023 144 Form 144 - Report of proposed sale of securities:
06/09/2023 4 Deschatelets Pascal (Chief Scientific Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Sold 12,000 shares @ $91.35, valued at $1.1M
Exercised 18,500 options to buy @ $2.67, valued at $49.4k
06/08/2023 144 Form 144 - Report of proposed sale of securities:
05/09/2023 4 Deschatelets Pascal (Chief Scientific Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Sold 12,000 shares @ $92.39, valued at $1.1M
Exercised 18,500 options to buy @ $2.67, valued at $49.4k
05/08/2023 144 Form 144 - Report of proposed sale of securities:
03/10/2023 4 Deschatelets Pascal (Chief Scientific Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Sold 12,000 shares @ $63.79, valued at $765.5k
Exercised 18,500 options to buy @ $2.67, valued at $49.4k
02/22/2023 4 Deschatelets Pascal (Chief Scientific Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Granted 9,886 shares @ $0
Paid exercise price by delivering 1,195 shares @ $58.5, valued at $69.9k
Granted 14,023 options to buy @ $35.46, valued at $497.3k
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/30/2023 4 Deschatelets Pascal (Chief Scientific Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 832 shares @ $52.77, valued at $43.9k
01/24/2023 4 Deschatelets Pascal (Chief Scientific Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 2,326 shares @ $52.05, valued at $121.1k
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/10/2023 4 Deschatelets Pascal (Chief Scientific Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Sold 12,000 shares @ $46.08, valued at $553k
Exercised 18,500 options to buy @ $2.67, valued at $49.4k
12/30/2022 4 Deschatelets Pascal (Chief Scientific Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Exercised 7,000 options to buy @ $3.67, valued at $25.7k
12/12/2022 4 Deschatelets Pascal (Chief Scientific Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Sold 12,000 shares @ $47.5, valued at $570k
Exercised 18,500 options to buy @ $2.67, valued at $49.4k
10/11/2022 4 Deschatelets Pascal (Chief Scientific Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Sold 12,000 shares @ $57.5, valued at $690k
Exercised 18,500 options to buy @ $2.67, valued at $49.4k
09/12/2022 4 Deschatelets Pascal (Chief Scientific Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Sold 12,000 shares @ $63.98, valued at $767.8k
Exercised 18,500 options to buy @ $2.67, valued at $49.4k
07/12/2022 4 Deschatelets Pascal (Chief Scientific Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Sold 12,000 shares @ $47.95, valued at $575.4k
Exercised 12,000 options to buy @ $2.67, valued at $32k
Exercised 6,500 options to buy @ $2.67, valued at $17.4k
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/02/2022 4 Deschatelets Pascal (Chief Scientific Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Disposed of 1,875 shares @ $0
Sold 4,000 shares @ $44.43, valued at $177.7k
Disposed of 11,250 options to buy @ $44.9, valued at $505.1k
Exercised 4,000 options to buy @ $2.67, valued at $10.7k
02/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2022 4 Deschatelets Pascal (Chief Scientific Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 931 shares @ $38.59, valued at $35.9k
01/25/2022 4 Deschatelets Pascal (Chief Scientific Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Granted 26,051 shares @ $0
Granted 36,951 options to buy @ $35.46, valued at $1.3M
06/25/2021 4 Deschatelets Pascal (Chief Scientific Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Sold 6,250 shares @ $65.61, valued at $410.1k
Exercised 6,250 options to buy @ $2.67, valued at $16.7k
05/25/2021 4 Deschatelets Pascal (Chief Scientific Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Exercised 6,250 options to buy @ $2.67, valued at $16.7k
Sold 6,250 shares @ $47.4, valued at $296.3k
04/29/2021 4 Deschatelets Pascal (Chief Scientific Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Exercised 4,500 options to buy @ $2.67, valued at $12k
04/26/2021 4 Deschatelets Pascal (Chief Scientific Officer) has filed a Form 4 on Apellis Pharmaceuticals, Inc.
Txns: Sold 6,250 shares @ $46.13, valued at $288.3k
Exercised 6,250 options to buy @ $2.67, valued at $16.7k
03/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy